Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra
- PMID:10092080
- DOI: 10.1002/(SICI)1521-4141(199903)29:03<781::AID-IMMU781>3.0.CO;2-0
Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra
Abstract
Three molecular forms of the IL-1 receptor antagonist (IL-1ra) have been identified and cloned. Secreted IL-1ra (sIL-1ra or IL-1ra1) contains a classical leader peptide giving a released mature protein. Two intracellular isoforms, icIL-1ra type I (IL-1ra2) and icIL-1ra type II (IL-1ra3), have no leader sequence, thus predicting that these proteins remain intracellular. In an effort to define its biological role, we structurally and functionally characterized IL-1ra3. Endogenous immunoreactive IL-1ra3 was detected in a variety of inflammatory cells and tissues. We used a gene transfer strategy to explore the possible intracellular functions of IL-1ra3 (and IL-1ra2) and the cell-associated agonist IL-1alpha. The intracellular IL-1ra3 isoform, as well as IL-1ra2, does not block the action of exogenous and endogenous IL-1 under these conditions. Intact IL-1ra3 was released from the cells killed by NK effectors. The intracellular isoforms may represent a reservoir of IL-1ra, released upon cell death, whose function is to limit the pro-inflammatory action of cell debris.
Similar articles
- Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.Gabay C, et al.Arthritis Rheum. 2001 Feb;44(2):451-62. doi: 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.0.CO;2-H.Arthritis Rheum. 2001.PMID:11229477
- Production of interleukin-1 receptor antagonist by human articular chondrocytes.Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C.Palmer G, et al.Arthritis Res. 2002;4(3):226-31. doi: 10.1186/ar411. Epub 2002 Apr 8.Arthritis Res. 2002.PMID:12010575Free PMC article.
- Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis.Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Maret M, Arend WP, Gabay C.Palmer G, et al.Eur J Immunol. 2003 Feb;33(2):434-40. doi: 10.1002/immu.200310018.Eur J Immunol. 2003.PMID:12645941
- Interleukin-1 receptor antagonist.Lennard AC.Lennard AC.Crit Rev Immunol. 1995;15(1):77-105. doi: 10.1615/critrevimmunol.v15.i1.30.Crit Rev Immunol. 1995.PMID:8519423Review.
- Interleukin-1 receptor antagonist: role in biology.Arend WP, Malyak M, Guthridge CJ, Gabay C.Arend WP, et al.Annu Rev Immunol. 1998;16:27-55. doi: 10.1146/annurev.immunol.16.1.27.Annu Rev Immunol. 1998.PMID:9597123Review.
Cited by
- The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.Palmer G, Burger D, Mezin F, Magne D, Gabay C, Dayer JM, Guerne PA.Palmer G, et al.Arthritis Res Ther. 2004;6(3):R181-9. doi: 10.1186/ar1157. Epub 2004 Feb 19.Arthritis Res Ther. 2004.PMID:15142263Free PMC article.
- Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.Klueh U, Liu Z, Feldman B, Kreutzer D.Klueh U, et al.J Diabetes Sci Technol. 2010 Sep 1;4(5):1073-86. doi: 10.1177/193229681000400506.J Diabetes Sci Technol. 2010.PMID:20920427Free PMC article.
- Biological role of interleukin 1 receptor antagonist isoforms.Arend WP, Guthridge CJ.Arend WP, et al.Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i60-4. doi: 10.1136/ard.59.suppl_1.i60.Ann Rheum Dis. 2000.PMID:11053091Free PMC article.Review.
- Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, Schmitt I, Klockgether T, Wüllner U.Evert BO, et al.J Neurosci. 2001 Aug 1;21(15):5389-96. doi: 10.1523/JNEUROSCI.21-15-05389.2001.J Neurosci. 2001.PMID:11466410Free PMC article.
- Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.Luheshi NM, Rothwell NJ, Brough D.Luheshi NM, et al.Br J Pharmacol. 2009 Aug;157(8):1318-29. doi: 10.1111/j.1476-5381.2009.00331.x.Br J Pharmacol. 2009.PMID:19681864Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources